D. Becker

发表

Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas

K. Hoek, A. P. Smith, D. Becker, 2005, Cancer biology & therapy.

Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein.

T. Jovin, D. Arndt-Jovin, D. Becker, 2010, The Journal of investigative dermatology.

Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle

K. Walgenbach, D. Becker, K. Shestak, 1995, Nature Medicine.

Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas.

M. Herlyn, S. Beebe, D. Becker, 1990, Oncogene.

Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor.

M. Herlyn, M. Herlyn, D. Becker, 1989, The EMBO journal.

New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.

L. Chin, M. Hendrix, M. Herlyn, 2002, The American journal of pathology.

The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas

D. Becker, Xiaolei Wang, Chitralekha Bhattacharya, 2012, Molecular Cancer.

Loss of heterozygosity at chromosomal regions 3p and 13q in non-small-cell carcinoma of the lung represents low-frequency events.

D. Becker, A. Şahin, 1989, Genomics.

Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation.

M. Herlyn, M. Herlyn, U. Rodeck, 1992, Oncogene.

Cellular transforming genes in cancer.

G. Cooper, D. Becker, M. Lane, 1983, Haematology and blood transfusion.

Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death

A. Giese, C. Griesinger, D. Arndt-Jovin, 2017, Proceedings of the National Academy of Sciences of the United States of America.

Proteomic analysis of laser microdissected melanoma cells from skin organ cultures.

T. Conrads, A. Wells, B. Hood, 2010, Journal of proteome research.

Transforming activity of nasopharyngeal carcinoma DNA detectable in mouse JB6 cells

N. Colburn, N. Raab-Traub, D. Winterstein, 1989, International journal of cancer.

Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.

J. Kirkwood, D. Farkas, D. Tweardy, 1999, Molecular medicine.

Identification of an antigen associated with transforming genes of human and mouse mammary carcinomas.

G. Cooper, D. Becker, M. Lane, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Macroscopic Spectral Imaging and Gene Expression Analysis of the Early Stages of Melanoma

D L Farkas, J. Kirkwood, D. Farkas, 1999, Molecular medicine.

Molecular analysis of melanoma precursor lesions.

J. Kirkwood, R. Mascari, U. Rao, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Growth and phenotypic characteristics of human nevus cells in culture.

W. Clark, M. Herlyn, U. Rodeck, 1988, The Journal of investigative dermatology.

Functional analysis and molecular targeting of aurora kinases a and B in advanced melanoma.

S. Moschos, D. Becker, Xiaolei Wang, 2010, Genes & cancer.

The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas

D. Becker, Xiaolei Wang, Chitralekha Bhattacharya, 2012, Molecular Cancer.

Structural and Functional Characteristics of Human Melanoma

M. Herlyn, U. Graeven, D. Becker, 1991 .

SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas

D. Jukic, J. Kirkwood, C. Athanassiou, 2007, Oncogene.

SAGE Identification and Fluorescence Imaging Analysis of Genes and Transcripts in Melanomas and Precursor Lesions

P. Meltzer, A. Weeraratna, A. P. Smith, 2004, Cancer biology & therapy.

Melanoma cell invasiveness is promoted at least in part by the Epidermal Growth Factor-like repeats of Tenascin-C

A. Wells, J. Grahovac, D. Becker, 2012, The Journal of investigative dermatology.

Expression Analysis of Genes identified by Molecular Profiling of VGP Melanomas and MGP Melanoma-Positive Lymph Nodes

J. Kirkwood, D. Becker, H. Edington, 2004, Cancer biology & therapy.

Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma

D. Becker, Xiaolei Wang, C. Abdullah, 2011, Cell cycle.

Expression of bfgf and differential expression of fgf receptors in normal human myoblasts and rhabdomyosarcomas.

D. Becker, J. Vignovich, 1993, International journal of oncology.

Molecular therapy for melanoma: Useful and not useful targets

D. Becker, Xiaolei Wang, C. Abdullah, 2010, Cancer biology & therapy.

Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.

D. Becker, Y. Wang, 1996, Oncogene.

Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

D. Becker, Yiping Wang, 1997, Nature Medicine.

Differential expression of cyclic AMP-dependent protein kinase isozymes in normal human melanocytes and malignant melanomas.

S. Beebe, D. Becker, P. Salomonsky, 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Markers and tissue resources for melanoma: meeting report.

V. Sondak, M. Mihm, S. Hewitt, 2006, Cancer research.

Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome

M. Bittner, R. Strausberg, P. Meltzer, 2004, Oncogene.

Suppressing the high-level expression and function of ATM in advanced-stage melanomas does not sensitize the cells to ionizing radiation

D. Jukic, S. Moschos, D. Becker, 2009, Cancer biology & therapy.

Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.

D. Jukic, R. Dhir, C. Athanassiou, 2010, Human pathology.

Importance of glycolysis and oxidative phosphorylation in advanced melanoma

J. Kirkwood, J. Ho, B. Van Houten, 2012, Molecular Cancer.

Mitochondrial Respiration - An Important Therapeutic Target in Melanoma

J. Kirkwood, T. Conrads, B. Van Houten, 2012, PloS one.

The role of N-Cadherin, MCAM, and β3 integrin in melanoma progression, proliferation, migration and invasion

D. Becker, K. Watson-Hurst, 2006, Cancer biology & therapy.

Pathologic and gene expression features of metastatic melanomas to the brain

D. Kondziolka, J. Kirkwood, M. Romkes, 2013, Cancer.

Noninvasive Dynamic Fluorescence Imaging of Human Melanomas Reveals that Targeted Inhibition of bFGF or FGFR-1 in Melanoma Cells Blocks Tumor Growth by Apoptosis

Dorothea Becker, Daniel L Farkas, D. Farkas, 2002, Molecular medicine.

Isolation and analysis of novel human melanocyte-specific cDNA clones.

M. Herlyn, D. Becker, C. Gratas, 1994, DNA and cell biology.

Basic fibroblast growth factor in human melanoma.

M. Herlyn, U. Rodeck, D. Becker, 1991, Cancer cells.

Importance of glycolysis and oxidative phosphorylation in advanced melanoma

J. Kirkwood, J. Ho, S. Moschos, 2012, Molecular Cancer.

Systemic Interferon-α (IFN-α) Treatment Leads to Stat3 Inactivation in Melanoma Precursor Lesions

Daniel L. Farkas, John M. Kirkwood, Dorothea Becker, 1999 .

Applications of spectral imaging: detection and analysis of human melanoma and its precursors.

D L Farkas, D. Farkas, D. Becker, 2001, Pigment cell research.

Optical Imaging Analysis of Atypical Nevi and Melanoma

A. P. Smith, D. Becker, 2006 .

Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.

D. Becker, P. Yang, 2000, International journal of oncology.